Literature DB >> 17063423

[Reproducibility of dynamic contour tonometry. Comparison with TonoPenXL and Goldmann applanation tonometry - a clinical study on 323 normal eyes].

A Viestenz1, A Langenbucher, A Viestenz1.   

Abstract

BACKGROUND: The PASCAL Dynamic Contour Tonometer (DCT) is a new diagnostic approach for the digital measurement of intraocular pressure (IOP) in eyes with glaucoma. The aim of this study was to evaluate the reproducibility of DCT in normal eyes and to compare DCT with Goldmann applanation tonometry (GAT) and TonoPenXL. PATIENTS AND METHODS: A prospective cross-sectional study on 323 normal, consecutive eyes was performed. Eyes with an IOP of more than 23 mmHg (GAT) were excluded. Central corneal power (Zeiss Ophthalmometer) and central corneal thickness (ultrasound pachymetry: Tomey AL-1000) were taken. The IOP readings were obtained as follows: 3 x DCT [quality of measurement, IOP and ocular pulse amplitude (OPA) were taken], 1 x TonoPenXL, GAT, finally: once again DCT to evaluate the tonography effect.
RESULTS: The quality of 3 following IOP (DCT) readings was good (quality Q1 = 43.4 %, Q2 = 32.5 %, Q3 = 22.7 %). The reproducibility of the IOP (DCT) measurements was excellent (first measurement IOP (DCT) = 18.1 +/- 3.4 mmHg, second measurement IOP (DCT) = 18.1 +/- 3.4 mmHg, third measurement IOP (DCT) = 17.8 +/- 3.4 mmHg, Cronbach's alpha = 0.976). First and second IOP (DCT) values showed a strong correlation (r = 0.93). A significant tonography effect was observed between first and third IOP (DCT) measurements (0.4 mmHg; p = 0.004). Mean OPA (DCT) was 3.0 mmHg during the first three measurements (Cronbach's alpha = 0.964). IOP (DCT) and OPA (DCT) reproducibility showed no laterality. IOP (DCT) (17.7 +/- 3.4 mmHg) was significantly higher than IOP (TonoPenXL) (16.0 +/- 3.2 mmHg, n = 275; p < 0.001) and higher than IOP (GAT) (14.5 +/- 3.1 mmHg, n = 275; p < 0.001). The effect of tonography between the third and last IOP (DCT) measurement was zero (p = 0.6). IOP (DCT) and IOP (GAT) values were only weak correlated with central corneal thickness.
CONCLUSIONS: IOP and OPA values measured with the DCT are extraordinary reproducible in normal eyes. Frequently, DCT detects higher IOP values than those obtained with TonoPenXL and GAT. A reproducible measurement of IOP and OPA may open new diagnostic fields, e. g., in glaucoma detection or ocular vascular diseases.

Entities:  

Mesh:

Year:  2006        PMID: 17063423     DOI: 10.1055/s-2006-926862

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  6 in total

1.  [Evaluation of dynamic contour tonometry in penetrating keratoplasties].

Authors:  An Viestenz; A Langenbucher; B Seitz; Ar Viestenz
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

2.  [Mobile intraocular pressure measurement. From palpation to initial clinical experience with the handheld dynamic contour tonometer].

Authors:  U Schmid; C Kniestedt
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

3.  [A comparison of rebound tonometry (ICare) with TonoPenXL and Goldmann applanation tonometry].

Authors:  W Schreiber; C K Vorwerk; A Langenbucher; W Behrens-Baumann; A Viestenz
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

4.  [Reduction of intraocular pressure and ocular pulse amplitude during general anesthesia].

Authors:  H Zuche; E Morinello; A Viestenz; M Fiorentzis; B Seitz; T Volk; A Viestenz
Journal:  Ophthalmologe       Date:  2015-09       Impact factor: 1.059

5.  Measurement of Intraocular Pressure with Applanation, Dynamic Contour, and Air-Puff Tonometers: A Comparative Study in Primary Open-Angle Glaucoma and Healthy Cases.

Authors:  Kemal Turgay Özbilen; M Selim Kocabora
Journal:  Beyoglu Eye J       Date:  2020-12-28

6.  [Intraocular pressure elevation after vitrectomy-Goldmann applanation tonometry measures lower intraocular pressure than dynamic contour tonometry].

Authors:  Sebastian Bäurle; Anja Viestenz; Berthold Seitz; Arne Viestenz
Journal:  Ophthalmologe       Date:  2021-07-06       Impact factor: 1.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.